Paladin Advisory Group’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,020
Closed -$63.9K 249
2025
Q2
$63.9K Hold
1,020
0.05% 132
2025
Q1
$61.4K Hold
1,020
0.05% 137
2024
Q4
$59.5K Hold
1,020
0.05% 141
2024
Q3
$60.4K Hold
1,020
0.04% 140
2024
Q2
$56.3K Hold
1,020
0.04% 140
2024
Q1
$59K Hold
1,020
0.05% 134
2023
Q4
$55K Sell
1,020
-1,002
-50% -$48.9K 0.05% 136
2023
Q3
$98.1K Sell
2,022
-666
-25% -$35.4K 0.08% 119
2023
Q2
$152K Hold
2,688
0.12% 103
2023
Q1
$145K Buy
+2,688
New +$143K 0.12% 107
2022
Q2
Sell
-2,688
Closed -$147K 381
2022
Q1
$165K Buy
+2,688
New +$160K 0.13% 105

Other funds holding IHI

Paladin Advisory Group's IHI Position: Q3 2025 in Review

Paladin Advisory Group sold out of iShares US Medical Devices ETF (IHI) in Q3 2025, closing a stake of 1,020 shares — an estimated $63.9K sold.

Paladin Advisory Group first reported a position in IHI in Q1 2022 and held it in 11 quarters. The position peaked at $165K in Q1 2022. 526 funds tracked by Wall St. Rank hold IHI as of Q3 2025.

  • Paladin Advisory Group reported no remaining iShares US Medical Devices ETF position as of Q3 2025 after selling out during the quarter.
  • Paladin Advisory Group sold 1,020 iShares US Medical Devices ETF shares in Q3 2025, an estimated $63.9K.
  • Paladin Advisory Group first reported a position in iShares US Medical Devices ETF in Q1 2022 and held it in 11 quarters.
  • Paladin Advisory Group's iShares US Medical Devices ETF position peaked at $165K in Q1 2022.
  • 526 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2025.

Based on Paladin Advisory Group's 13F filing for Q3 2025, filed 5 Nov 2025.